Novo Nordisk Beats Sanofi To Keep Injection Pen Patent
Novo Nordisk can keep a patent for an injection device with a display panel showing the dose given to a patient, as European appellate officials dismissed claims from Sanofi-Aventis and Medmix...To view the full article, register now.
Already a subscriber? Click here to view full article